Clinical Trial Update: Plasma i-FABP as Predictor for Irreversible Bowel Ischemia

View source ↗

Summary

A trial update evaluating plasma i-FABP as a potential biomarker to predict irreversible bowel ischemia in acute mesenteric ischemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bowel Necrosis
• Mesenteric Ischemia

Snippet

Sponsor: University Hospital Regensburg | Conditions: Acute Mesenteric Ischemia, Bowel Necrosis | Status: UNKNOWN